Condition: Degenerative Disc Disease · Spine Fusion · Leg Pain and/or Back Pain · Sponsor: Kuros Biosurgery AG
This is a phase IV post-marketing study for MagnetOs Flex Matrix. MagnetOs Flex Matrix is a synthetic bone graft extender product that is routinely used by surgeons as a treatment for patients with degenerative disc disease and undergoing spinal fusion surgery. In this study, MagnetOs Flex Matrix will be used according to the latest U.S. Instructions For Use, specifically as a bone graft extender mixed with autograft in a 1:1 vol.% in the posterolateral spine. Trinity Elite will also be used according to its latest IFU approved in the US. Specifically, this cellular based allograft is an allograft intended for the treatment of musculoskeletal defects.
This description comes directly from the study's public registry record.
Cesar Silva, MD · 9702156793 · cesar.silva@kurosbio.com
Always discuss trial participation with your own doctor first.
| Hartford Hospital | Hartford, Connecticut, United States | Recruiting |
| Rush University Medical Center | Chicago, Illinois, United States | Recruiting |
| MedStar Health Research Institute | Columbia, Maryland, United States | Recruiting |
| Michigan Orthopedic Surgeons | Bloomfield Hills, Michigan, United States | Recruiting |
| Pinehurst Surgical Clinic | Pinehurst, North Carolina, United States | Recruiting |
| The Ohio State University | Columbus, Ohio, United States | Recruiting |
| Huntsman Spinal Clinic | Salt Lake City, Utah, United States | Recruiting |
| Inova Healthcare | Fairfax, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05037968